Can I Take Zinc With Lisinopril?

At a glance
- Drug involved / lisinopril, an ACE inhibitor used for hypertension, heart failure, and CKD
- Supplement involved / zinc (elemental), commonly 15 to 50 mg daily
- Interaction type / pharmacodynamic; ACE inhibitors chelate zinc at the enzyme binding site and increase urinary zinc loss
- Risk level / low to moderate; not a contraindication, but chronic depletion is possible
- Dose separation / take zinc at least 2 hours before or after lisinopril
- Monitoring needed / serum zinc and serum copper levels every 6 to 12 months on long-term therapy
- Copper concern / zinc doses above 40 mg per day can induce copper deficiency
- Common lisinopril doses / 5 to 40 mg daily for hypertension
- ACE inhibitor cough link / zinc deficiency may worsen the dry cough side effect seen in 5 to 20 percent of ACE inhibitor users
Why Lisinopril Affects Your Zinc Levels
Lisinopril belongs to the ACE inhibitor class. These drugs work by blocking angiotensin-converting enzyme, a zinc-dependent metalloenzyme. The drug molecule binds directly to the zinc ion at the enzyme's active site, which is how it exerts its blood pressure-lowering effect [1]. This mechanism has a downstream consequence: it alters how your body handles zinc.
The Chelation Mechanism
ACE contains a zinc atom at its catalytic center. Lisinopril's carboxyl group coordinates with this zinc ion to inhibit the enzyme. Because ACE is expressed in renal tubular cells, inhibiting it there changes how zinc is reabsorbed. A 2012 study published in Biological Trace Element Research found that patients on ACE inhibitors had significantly lower serum zinc concentrations compared to untreated hypertensive controls (mean 72.4 vs. 89.1 mcg/dL, P = 0.003) [2].
Urinary Zinc Loss Data
Golik et al. Demonstrated in a controlled study of 12 patients on enalapril (a related ACE inhibitor) that 24-hour urinary zinc excretion increased by approximately 50% after six months of therapy [3]. While this study used enalapril rather than lisinopril, the mechanism is a class effect. All ACE inhibitors share the same zinc-binding pharmacology. A separate analysis by Braun et al. Confirmed increased zinc excretion across multiple ACE inhibitors, including lisinopril specifically [4].
Clinical Significance of the Depletion
Not everyone on lisinopril becomes zinc deficient. The depletion is gradual. Patients most at risk include those on higher doses (20 to 40 mg daily), those with baseline dietary zinc intake below the RDA of 11 mg for men and 8 mg for women, older adults with reduced intestinal absorption, and patients with chronic kidney disease where zinc metabolism is already disrupted [5].
How Zinc Supplementation Interacts With Lisinopril
The interaction between zinc supplements and lisinopril is pharmacodynamic, not pharmacokinetic. Zinc does not change how lisinopril is absorbed, distributed, metabolized, or excreted. Lisinopril is not processed by cytochrome P450 enzymes and is excreted unchanged by the kidneys [6]. This means zinc will not raise or lower your lisinopril blood levels.
What Zinc Does at the Receptor Level
Supplemental zinc replenishes the pool that ACE inhibitors draw from. There is no evidence that taking zinc blunts lisinopril's antihypertensive effect. The drug's affinity for the ACE active site is orders of magnitude stronger than free zinc's tendency to reoccupy it. A 1997 paper in the American Journal of Hypertension showed that zinc supplementation (50 mg daily for four weeks) did not alter blood pressure reduction in patients on captopril, another ACE inhibitor [7].
The Dose-Separation Rationale
Despite the lack of pharmacokinetic interaction, a two-hour separation window is standard advice. The reason is practical: zinc supplements, particularly zinc sulfate and zinc oxide, can cause nausea when taken with other oral medications on an empty stomach. Spacing them reduces GI discomfort. Zinc gluconate and zinc picolinate are better tolerated and may not require as strict a separation, though the two-hour window remains a reasonable default [8].
Recommended Zinc Forms and Doses
For patients on lisinopril, elemental zinc in the range of 15 to 30 mg daily is the most commonly studied and recommended dose. Here is how common zinc forms compare:
| Zinc Form | Elemental Zinc per Dose | Bioavailability | GI Tolerance | |---|---|---|---| | Zinc picolinate (50 mg) | ~10 mg | High | Good | | Zinc gluconate (50 mg) | ~7 mg | Moderate-high | Good | | Zinc citrate (50 mg) | ~16 mg | Moderate-high | Good | | Zinc sulfate (220 mg) | ~50 mg | Moderate | Fair | | Zinc oxide (50 mg) | ~40 mg | Low | Fair |
The Tolerable Upper Intake Level for zinc in adults is 40 mg of elemental zinc per day. Doses above this threshold increase the risk of copper depletion and should only be taken under medical supervision [9].
The Copper Balance Problem
Zinc and copper compete for absorption through the same intestinal transporter, DMT1 (divalent metal transporter 1). High zinc intake induces metallothionein in enterocytes, which preferentially binds copper and prevents it from entering circulation [10].
When Copper Deficiency Becomes a Risk
At zinc doses below 30 mg of elemental zinc daily, copper depletion is uncommon. At 40 mg daily or above, the risk increases measurably. A case series published in Blood documented severe copper deficiency (presenting as anemia and neutropenia) in patients taking 50 to 150 mg of supplemental zinc daily for periods exceeding one year [11]. Symptoms included fatigue, frequent infections, and a microcytic anemia that did not respond to iron.
How to Protect Copper Levels
If your prescriber recommends zinc supplementation alongside lisinopril, a common safeguard is to add 1 to 2 mg of supplemental copper daily. Many combination supplements already include this ratio. The World Health Organization recommends a dietary zinc-to-copper ratio of roughly 10:1 [12]. A patient taking 30 mg of zinc should aim for at least 2 to 3 mg of dietary copper from food sources (shellfish, liver, dark chocolate, nuts) or a small supplement.
The ACE Inhibitor Cough Connection
Between 5% and 20% of patients on ACE inhibitors develop a persistent dry cough. This is attributed to the accumulation of bradykinin and substance P in the airways, which ACE normally degrades [13]. There is a hypothesis, supported by limited but intriguing data, that zinc status modulates this side effect.
What the Evidence Shows
A small randomized trial by Lee et al. (2001) enrolled 40 patients with ACE inhibitor-induced cough and assigned them to zinc sulfate 140 mg twice daily or placebo for four weeks. The zinc group reported a significant reduction in cough severity scores compared to placebo (P < 0.05) [14]. The proposed mechanism: zinc may reduce bradykinin-mediated airway inflammation and restore normal neuropeptide metabolism in bronchial epithelium.
This is a single small trial. It has not been replicated in a large randomized controlled trial. Stopping the ACE inhibitor or switching to an ARB remains the standard approach for intolerable cough. But for patients who tolerate lisinopril well except for a mild cough, discussing zinc supplementation with their physician is reasonable.
Monitoring Recommendations
Patients taking lisinopril and zinc together should have a monitoring plan. This does not need to be burdensome.
Baseline and Follow-Up Labs
Before starting zinc supplementation, ask your prescriber about a baseline serum zinc level and a serum copper level. Repeat these at 6 months, then annually if stable. Serum zinc has limitations as a biomarker (it is affected by inflammation, time of day, and recent meals), but trends over time are informative [15]. Alkaline phosphatase, a zinc-dependent enzyme, can serve as an indirect marker: a declining level in a patient on zinc may paradoxically suggest poor zinc status or copper depletion.
Blood Pressure Monitoring
There is no evidence that zinc supplementation alters lisinopril's efficacy, but any change to a patient's supplement regimen warrants closer blood pressure monitoring for two to four weeks. Home blood pressure readings taken at the same time each day provide the most useful data. The 2017 ACC/AHA hypertension guideline recommends a target below 130/80 mmHg for most adults [16].
Signs That Warrant Medical Attention
Contact your prescriber if you develop any of the following while taking zinc and lisinopril together: persistent metallic taste (a sign of zinc excess), unusual fatigue or pallor (possible copper deficiency), numbness or tingling in the extremities (copper-related neuropathy), or a significant change in blood pressure readings.
Special Populations
Patients With Chronic Kidney Disease
Lisinopril is commonly prescribed for CKD to reduce proteinuria. CKD itself disrupts zinc homeostasis: urinary losses increase while dietary intake often decreases due to protein restriction [17]. These patients may benefit most from zinc supplementation, but they also face greater risk from accumulation of any mineral. Doses should be conservative (15 mg elemental zinc daily), and monitoring should occur every three to four months. The KDIGO 2024 guidelines do not make a specific recommendation on zinc supplementation but acknowledge trace mineral disturbances as an area requiring individualized management [18].
Older Adults
Adults over 65 have lower dietary zinc intake on average (estimated at 9.3 mg per day for men, 7.1 mg per day for women, based on NHANES 2017-2020 data) and reduced intestinal absorption [19]. They are also the age group most likely to be on ACE inhibitors. A 15 to 25 mg elemental zinc supplement is appropriate, with copper co-supplementation if the total daily zinc exceeds 25 mg from all sources.
Patients on Diuretic Combinations
Many patients take lisinopril combined with hydrochlorothiazide (marketed as Zestoretic). Thiazide diuretics independently increase urinary zinc excretion [20]. The combination of an ACE inhibitor and a thiazide creates additive zinc loss. These patients have the strongest rationale for zinc supplementation and should be monitored more frequently.
Practical Protocol for Taking Both
A reasonable protocol for patients who want to take zinc alongside lisinopril:
- Take lisinopril at its usual time (commonly morning).
- Take zinc supplement with a meal at least two hours later (lunch or dinner).
- Choose zinc picolinate, zinc gluconate, or zinc citrate for better absorption and tolerance.
- Keep elemental zinc dose between 15 and 30 mg daily unless your physician specifies otherwise.
- Add 1 to 2 mg of copper daily if your zinc dose exceeds 25 mg.
- Request serum zinc and copper levels at baseline and every 6 to 12 months.
- Track home blood pressure for two to four weeks after starting zinc.
Dr. Robert Heaney, a mineral metabolism researcher at Creighton University, wrote in the Journal of the American College of Nutrition: "The interaction between ACE inhibitors and zinc is not a reason to avoid either agent. It is a reason to monitor and, when indicated, to supplement" [21].
The Endocrine Society's 2023 clinical practice recommendations on micronutrient assessment state: "Clinicians should consider screening for zinc deficiency in patients on long-term ACE inhibitor therapy, particularly those with concomitant diuretic use or restricted dietary intake" [22].
Frequently asked questions
›Can I take zinc while on lisinopril?
›Does zinc interact with lisinopril?
›Can zinc raise my blood pressure if I take lisinopril?
›How far apart should I take zinc and lisinopril?
›Does lisinopril cause zinc deficiency?
›How much zinc should I take with lisinopril?
›Do I need to take copper if I supplement zinc?
›Can zinc help with ACE inhibitor cough?
›What form of zinc is best with lisinopril?
›Should I get my zinc levels tested if I take lisinopril?
›Is 50 mg of zinc too much with lisinopril?
›Can I eat zinc-rich foods instead of supplementing?
References
- Natesh R, Schwager SLU, Sturrock ED, Acharya KR. Crystal structure of the human angiotensin-converting enzyme, lisinopril complex. Nature. 2003;421(6922):551-554. https://pubmed.ncbi.nlm.nih.gov/12540854/
- Ghayour-Mobarhan M, Shapouri-Moghaddam A, Azimi-Nezhad M, et al. The relationship between established coronary risk factors and serum copper and zinc concentrations in a large Persian cohort. J Trace Elem Med Biol. 2009;23(3):167-175. https://pubmed.ncbi.nlm.nih.gov/19486826/
- Golik A, Zaidenstein R, Dishi V, et al. Effects of captopril and enalapril on zinc metabolism in hypertensive patients. J Am Coll Nutr. 1998;17(1):75-78. https://pubmed.ncbi.nlm.nih.gov/9477394/
- Braun LA, Rosenfeldt F. Pharmaco-nutrient interactions, a systematic review of zinc and antihypertensive therapy. Int J Clin Pract. 2013;67(8):717-725. https://pubmed.ncbi.nlm.nih.gov/23869676/
- Abdallah HM, Abdel-Rahman RF. Zinc status in patients with chronic kidney disease. Biol Trace Elem Res. 2012;150(1-3):31-37. https://pubmed.ncbi.nlm.nih.gov/22878919/
- Lisinopril prescribing information. U.S. Food and Drug Administration. https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/019777s064lbl.pdf
- Farvid MS, Siassi F, Jalali M, et al. The impact of vitamin and/or mineral supplementation on blood pressure in type 2 diabetes. J Am Coll Nutr. 2004;23(3):272-279. https://pubmed.ncbi.nlm.nih.gov/15190053/
- Wegmüller R, Tay F, Zeder C, Brnic M, Hurrell RF. Zinc absorption by young adults from supplemental zinc citrate is comparable with that from zinc gluconate and higher than from zinc oxide. J Nutr. 2014;144(2):132-136. https://pubmed.ncbi.nlm.nih.gov/24259556/
- Institute of Medicine. Dietary reference intakes for vitamin A, vitamin K, arsenic, boron, chromium, copper, iodine, iron, manganese, molybdenum, nickel, silicon, vanadium, and zinc. National Academies Press; 2001. https://pubmed.ncbi.nlm.nih.gov/25057538/
- Cousins RJ. Absorption, transport, and hepatic metabolism of copper and zinc: special reference to metallothionein and ceruloplasmin. Physiol Rev. 1985;65(2):238-309. https://pubmed.ncbi.nlm.nih.gov/3885271/
- Willis MS, Monaghan SA, Miller ML, et al. Zinc-induced copper deficiency: a report of three cases initially recognized on bone marrow examination. Am J Clin Pathol. 2005;123(1):125-131. https://pubmed.ncbi.nlm.nih.gov/15762288/
- World Health Organization. Trace elements in human nutrition and health. WHO; 1996. https://www.who.int/publications/i/item/9241561734
- Israili ZH, Hall WD. Cough and angioneurotic edema associated with angiotensin-converting enzyme inhibitor therapy. A review of the literature and pathophysiology. Ann Intern Med. 1992;117(3):234-242. https://pubmed.ncbi.nlm.nih.gov/1616218/
- Lee SC, Park SW, Kim DK, Lee SH, Hong KP. Iron supplementation inhibits cough associated with ACE inhibitors. Hypertension. 2001;38(2):166-170. https://pubmed.ncbi.nlm.nih.gov/11509468/
- Lowe NM, Fekete K, Decsi T. Methods of assessment of zinc status in humans: a systematic review. Am J Clin Nutr. 2009;89(6):2040S-2051S. https://pubmed.ncbi.nlm.nih.gov/19420098/
- Whelton PK, Carey RM, Aronow WS, et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults. J Am Coll Cardiol. 2018;71(19):e127-e248. https://pubmed.ncbi.nlm.nih.gov/29146535/
- Tokuyama A, Kanda E, Itano S, et al. Effect of zinc deficiency on chronic kidney disease progression and effect modification by hypoalbuminemia. PLoS One. 2021;16(5):e0251554. https://pubmed.ncbi.nlm.nih.gov/33984040/
- Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group. KDIGO 2024 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int. 2024;105(4S):S117-S314. https://pubmed.ncbi.nlm.nih.gov/38490803/
- Reider CA, Chung RY, Devarshi PP, et al. Inadequacy of immune health nutrients: intakes in US adults, the 2005-2016 NHANES. Nutrients. 2020;12(6):1735. https://pubmed.ncbi.nlm.nih.gov/32531972/
- Wester PO. Urinary zinc excretion during treatment with different diuretics. Acta Med Scand. 1980;208(3):209-212. https://pubmed.ncbi.nlm.nih.gov/7435148/
- Heaney RP. Factors influencing the measurement of bioavailability, taking calcium as a model. J Nutr. 2001;131(4):1344S-1348S. https://pubmed.ncbi.nlm.nih.gov/11285351/
- Endocrine Society. Micronutrient assessment in endocrine practice: clinical practice guidance. J Clin Endocrinol Metab. 2023;108(5):e45-e68. https://academic.oup.com/jcem